Literature DB >> 17223201

Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo.

Nicolle Sitte1, Melanie Busch, Shaaban A Mousa, Dominika Labuz, Heike Rittner, Carmen Gore, Hans Krause, Christoph Stein, Michael Schäfer.   

Abstract

Proopiomelanocortin (POMC)-derived beta-endorphin1-31 (END) released from immune cells inhibits inflammatory pain. We examined the expression of END and POMC mRNA encoding the signal sequence required for entry of the nascent polypeptide into the regulated secretory pathway in lymphocytes of rats with inflamed hindpaws. Within 12 h of inflammation, END increased in popliteal lymph nodes and at 96 h the intraplantar neutralization of END exacerbated pain. Lymphocytes expressed POMC, END, and full-length POMC mRNA. Semi-nested PCR revealed 8-fold increased exon 2-3 spanning POMC mRNA. Thus, painful inflammation enhances signal sequence-encoding lymphocytic POMC mRNA needed for regulated secretion of functionally active END.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223201     DOI: 10.1016/j.jneuroim.2006.11.033

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  20 in total

1.  Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis.

Authors:  Eric M Smith
Journal:  Brain Behav Immun       Date:  2007-09-27       Impact factor: 7.217

Review 2.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

3.  Blockade of intra-articular adrenergic receptors increases analgesic demands for pain relief after knee surgery.

Authors:  Ingo Kager; Shaaban A Mousa; Joachim Sieper; Christoph Stein; W Pipam; Rudolf Likar
Journal:  Rheumatol Int       Date:  2010-04-10       Impact factor: 2.631

4.  B Lymphocytes Express Pomc mRNA, Processing Enzymes and β-Endorphin in Painful Inflammation.

Authors:  Santhosh Chandar Maddila; Melanie Busch-Dienstfertig; Christoph Stein
Journal:  J Neuroimmune Pharmacol       Date:  2016-11-11       Impact factor: 4.147

5.  The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia.

Authors:  Hui Fan; Nian Gong; Teng-Fei Li; Ai-Niu Ma; Xiao-Yan Wu; Ming-Wei Wang; Yong-Xiang Wang
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

6.  JAK-STAT1/3-induced expression of signal sequence-encoding proopiomelanocortin mRNA in lymphocytes reduces inflammatory pain in rats.

Authors:  Melanie Busch-Dienstfertig; Dominika Labuz; Theresa Wolfram; Nicole N Vogel; Christoph Stein
Journal:  Mol Pain       Date:  2012-11-13       Impact factor: 3.395

Review 7.  Leukocytes as mediators of pain and analgesia.

Authors:  Heike L Rittner; Alexander Brack
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.686

8.  Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils.

Authors:  Heike L Rittner; Dagmar Hackel; Philipp Voigt; Shaaban Mousa; Andrea Stolz; Dominika Labuz; Michael Schäfer; Michael Schaefer; Christoph Stein; Alexander Brack
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

9.  Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain.

Authors:  Halina Machelska; Matthias Schroff; Detlef Oswald; Waltraud Binder; Nicolle Sitte; Shaaban A Mousa; Heike L Rittner; Alexander Brack; Dominika Labuz; Melanie Busch; Burghardt Wittig; Michael Schäfer; Christoph Stein
Journal:  Mol Pain       Date:  2009-12-14       Impact factor: 3.395

10.  IMT504 Provides Analgesia by Modulating Cell Infiltrate and Inflammatory Milieu in a Chronic Pain Model.

Authors:  Candelaria Leiguarda; Constanza Potilinski; Julia Rubione; Pablo Tate; Marcelo J Villar; Alejandro Montaner; Verónica Bisagno; Luis Constandil; Pablo R Brumovsky
Journal:  J Neuroimmune Pharmacol       Date:  2020-11-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.